Last week, Carlson Caspers was represented at the GPhA Conference. Partners Mark Schuman and Sam Lockner attended the 2013 Generic Pharmacuetical Association’s (GPhA) Annual Meeting in Orlando Florida from February 20-23, 2013.
According to the GPhA’s website:
[vision_pullquote style=”3″ align=”center”] The Generic Pharmaceutical Association (GPhA) is the nation’s leading trade association for manufacturers and distributors of generic prescription drugs, manufacturers of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic industry.
GPhA was founded in 2000, following the merger of three industry trade organizations: the Generic Pharmaceutical Industry Association, the National Association of Pharmaceutical Manufacturers, and the National Pharmaceutical Alliance. The three groups represented similar members, with the former two placing a greater emphasis on scientific issues and the latter focusing on sales and marketing issues. As GPhA, the industry now speaks with a stronger, unified voice before federal and state lawmakers, regulatory policymakers, and international agencies.
GPhA’s core purpose is to improve the lives of consumers by providing timely access to affordable pharmaceuticals. Toward this end, GPhA advances the interests of our member companies through initiatives in the scientific, regulatory, federal and state forums, international agencies, and in the public affairs arena.
GPhA members manufacture the vast majority of all affordable pharmaceuticals dispensed in the United States. Our products are used in nearly four billion prescriptions every year. [/vision_pullquote]